about
Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin SNeuromedin U receptor 2-deficient mice display differential responses in sensory perception, stress, and feeding.Identification of non-peptidic neuromedin U receptor modulators by a robust homogeneous screening assayPresynaptic modulation by neuromedin U of sensory synaptic transmission in rat spinal dorsal horn neuronesSpecies-dependent smooth muscle contraction to Neuromedin U and determination of the receptor subtypes mediating contraction using NMU1 receptor knockout miceNeuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia.Oncogenic features of neuromedin U in breast cancer are associated with NMUR2 expression involving crosstalk with members of the WNT signaling pathway.Intrathecal neuromedin U induces biphasic effects on sympathetic vasomotor tone, increases respiratory drive and attenuates sympathetic reflexes in rat.Neuromedin U type 1 receptor stimulation of A-type K+ current requires the βγ subunits of Go protein, protein kinase A, and extracellular signal-regulated kinase 1/2 (ERK1/2) in sensory neuronsOverexpression of neuromedin U is correlated with regional metastasis of head and neck squamous cell carcinoma.Neuromedin U receptor 2 does not play a role in the development of neuropathic pain following nerve injury in mice.The role of pacemaker currents in neuropathic pain.Functional genomics of the rat neuromedin U receptor 1 reveals a naturally occurring deleterious allele.
P2860
Q24656469-B3347EE1-33CF-4AEE-96ED-FF8A08F81735Q24672413-1EF60227-1B99-44EF-8454-94A5D4D4BB97Q28273552-E066FCE6-A60A-4341-8FE3-5B020F0053D3Q28575341-7C0A6335-A290-4449-BA51-A087CC297F85Q28580602-CBE83F6D-790B-422E-B8B7-61A6517188E3Q30441149-5A03E43D-8E42-495D-B0DA-5230F3CCE9B1Q33829465-E1CCCB46-2E73-4790-99EB-728172891B18Q35287373-B620E65B-7381-42EB-8D19-DD1845EA8044Q36002859-6B82AE17-9109-4003-972B-12E168245F38Q37082967-6CCC1CAC-B8C4-48AC-9000-7853A642B248Q43712077-9B76AB6E-D8BF-4517-B2AA-6257D117E6D3Q46893224-24ECF46A-9F1C-4BD9-BBAB-B05B75B03E61Q46966278-A2E3E0A3-72D8-4DA1-930B-E18439BF0FF7
P2860
description
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2003
@ast
im Jahr 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2003/01/01)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd op 2003/01/01)
@nl
наукова стаття, опублікована в січні 2003
@uk
مقالة علمية (نشرت عام 2003)
@ar
name
Pro-nociceptive effects of neuromedin U in rat
@ast
Pro-nociceptive effects of neuromedin U in rat
@en
Pro-nociceptive effects of neuromedin U in rat
@nl
type
label
Pro-nociceptive effects of neuromedin U in rat
@ast
Pro-nociceptive effects of neuromedin U in rat
@en
Pro-nociceptive effects of neuromedin U in rat
@nl
prefLabel
Pro-nociceptive effects of neuromedin U in rat
@ast
Pro-nociceptive effects of neuromedin U in rat
@en
Pro-nociceptive effects of neuromedin U in rat
@nl
P2093
P3181
P1433
P1476
Pro-nociceptive effects of neuromedin U in rat
@en
P2093
D. O'Donnell
F. Mennicken
M. Perkins
P304
P3181
P356
10.1016/S0306-4522(03)00300-2
P407
P577
2003-01-01T00:00:00Z